Logo image of ABOS

ACUMEN PHARMACEUTICALS INC (ABOS) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ABOS - US00509G2093 - Common Stock

2.14 USD
+0.18 (+9.18%)
Last: 12/12/2025, 8:12:44 PM
2.0901 USD
-0.05 (-2.33%)
After Hours: 12/12/2025, 8:12:44 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ABOS revenue by date.ABOS revenue by date.
1.7M1.44M
-15.29%

-100.00%
47.234M112.82M
138.85%
231.57M
105.26%
EBITDA
YoY % growth
ABOS ebitda by date.ABOS ebitda by date.
N/AN/A-16.395M-41.206M
-130.90%
-58.074M
-34.79%
-108.059M
-86.97%
-134.057M
-17.66%
28.197B
21,133.66%
45.049B
59.77%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ABOS ebit by date.ABOS ebit by date.
-7.81M-7.91M
-1.28%
-37.949M
-147.53%
-42.101M
-131.05%
-59.947M
-34.84%
-105.903M
-86.89%
-130.958M
-14.88%
-108.824M
16.90%
-118.32M
-8.73%
-69.392M
41.35%
-80.029M
-15.33%
-53.71M
32.89%
-11.658M
78.30%
80.291M
788.75%
Operating Margin
ABOS operating margin by date.ABOS operating margin by date.
-459.41%-549.31%N/AN/AN/AN/AN/AN/AN/AN/AN/A-113.71%-10.33%34.67%
EPS
YoY % growth
ABOS eps by date.ABOS eps by date.
N/AN/A-3.78-1.00
71.98%
-1.09
-1.89%
-1.61
-58.33%
-2.09
-22.21%
-1.54
26.29%
-1.13
26.57%
-2.20
-94.77%
-2.07
6.02%
-0.36
82.76%
0.64
280.00%
2.13
231.75%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.46
25.01%
-0.39
19.25%
-0.37
45.50%
-0.37
16.55%
-0.41
12.24%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-31.369M
20.65%
-29.549M
2.65%
-30.233M
27.53%
-29.274M
-10.61%
N/A
EBIT
Q2Q % growth
-30.134M
23.90%
-24.805M
18.32%
-23.29M
44.22%
-23.146M
12.70%
-24.476M
18.78%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.44
12.00%
-0.620.1828.53%
Q2 2025
Q2Q % growth
-0.68
-100.00%
-0.55-0.13-23.92%
Q1 2025
Q2Q % growth
-0.48
-92.00%
-0.680.2029.06%
Q4 2024
Q2Q % growth
-0.62
-121.43%
-0.49-0.13-26.63%
Q3 2024
Q2Q % growth
-0.50
-108.33%
-0.37-0.13-34.30%
Q2 2024
Q2Q % growth
-0.34
-21.43%
-0.29-0.05-19.05%
Q1 2024
Q2Q % growth
-0.25
10.71%
-0.270.025.73%
Q4 2023
Q2Q % growth
-0.28
12.50%
-0.27-0.01-5.58%
Q3 2023
Q2Q % growth
-0.24
7.69%
-0.270.0311.54%
Q2 2023
Q2Q % growth
-0.28
-12.00%
-0.350.0720.66%
Q1 2023
Q2Q % growth
-0.28
-21.74%
-0.350.0720.66%
Q4 2022
Q2Q % growth
-0.32
23.08%
-0.26-0.06-22.84%
Q3 2022
Q2Q % growth
-0.26
-160.00%
-0.23-0.03-10.92%
Q2 2022
Q2Q % growth
-0.25
96.84%
-0.250.00-0.04%
Q1 2022
Q2Q % growth
-0.23 -0.17-0.06-35.84%
Q4 2021
Q2Q % growth
-0.42 -0.14-0.27-187.21%
Q3 2021
Q2Q % growth
-0.10 -0.170.0742.44%
Q2 2021
Q2Q % growth
-7.91 -4.65-3.26-70.21%
ABOS Yearly EPS VS EstimatesABOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth

-100.00%
%
Q3 2021
Q2Q % growth

-100.00%
%
Q2 2021
Q2Q % growth

-100.00%
%
Q1 2021
Q2Q % growth

-100.00%
%
ABOS Yearly Revenue VS EstimatesABOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2030 2031 2032 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS14.48% 11.06% 10.79% 10.79%
RevenueN/A N/A N/A N/A